Methods, compositions and apparatuses for facilitating regeneration
Apparatuses, compositions and methods for removing cells which interfere with regenerative processes. The apparatuses, compositions and methods selectively kill partially functional and/or non-functional cells versus functional cells while protecting functional proliferative cells to the extent that, upon removal of the killed cells by disintegration or scavenging, functional cells replace the partially- or non-functional cells.
1. A method of promoting tissue or organ regeneration in a subject by killing senescent cells comprising a glycation end-product, the method comprising:
administering to the subject a humanized antibody that binds to the glycation end-product of a cell,
evaluating the subject to determine if senescent cells have been killed, and
readministering the antibody, if necessary,
wherein the subject is human, and
the humanized antibody retains constant regions which permit destruction of the cells by the subject's immune system.
2. The method of claim 1 , wherein the antibody is monoclonal.
3. The method of claim 2 , wherein the antibody is conjugated to a toxin.
4. The method of claim 1 , wherein the antibody is conjugated to a toxin.
5. A method of promoting regenerative processes or for overcoming aging effects in a subject, the method comprising:
administering to the subject a humanized antibody that binds to a glycation end-product of a cell,
evaluating the subject to determine if senescent cells have been killed, and
readministering the antibody, if necessary,
wherein the antibody selectively kills senescent cells,
the subject is human, and
the humanized antibody retains constant regions which permit destruction of the cells by the subject's immune system.
6. The method of claim 5 , wherein the antibody is monoclonal.
7. The method of claim 6 , wherein the antibody is conjugated to a toxin.
8. The method of claim 5 , wherein the antibody is conjugated to a toxin.
9. A method of selectively killing senescent cells in a subject, the method comprising:
administering to the subject a humanized antibody that binds to a glycation end-product of a cell,
evaluating the subject to determine if senescent cells have been killed, and
readministering the antibody, if necessary,
wherein the subject is human, and
the humanized antibody retains constant regions which permit destruction of the cells by the subject's immune system.
10. The method of claim 9 , wherein the antibody is monoclonal.
11. The method of claim 10 , wherein the antibody is conjugated to a toxin.
12. The method of claim 11 , wherein the antibody is conjugated to a toxin.